Comparison

SNIPER(ABL)-020 European Partner

Item no. HY-111872-10mg
Manufacturer MedChem Express
Amount 10 mg
Quantity options 10 mg 500mg 50 mg 5 mg
Category
Type Inhibitors
Specific against other
Purity 99.79
Formula C44H59ClN10O8S
Citations [1]Shibata N, et al. Development of protein degradation inducers of oncogenic BCR-ABL protein by conjugation of ABL kinase inhibitors and IAP ligands. Cancer Sci. 2017 Aug;108(8):1657-1666.
Smiles CC1=C(NC(C2=CN=C(NC3=CC(N4CCN(C(COCCOCCOCCNC([C@H](CC(C)C)NC([C@@H](O)[C@@H](CC5=CC=CC=C5)N)=O)=O)=O)CC4)=NC(C)=N3)S2)=O)C(Cl)=CC=C1
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Available
Product Description
SNIPER(ABL)-020, conjugating Dasatinib (ABL inhibitor) to Bestatin (IAP ligand) with a linker, induces the reduction of BCR-ABL protein[1].
StorageTemperature
-20°C (Powder, stored under nitrogen)
Shipping
Blue Ice
Manufacturers Applications
Cancer-Kinase/protease
MolecularWeight
923.52
Clinical Information
No Development Reported
Manufacturers Research Area
Cancer
Solubility
DMSO : 200 mg/mL (ultrasonic)
Target
Bcr-Abl; SNIPERs
Manufacturers Target
Bcr-Abl; SNIPERs
Manufacturers Pathway
PROTAC; Protein Tyrosine Kinase/RTK
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close